Windtree Receives Offer for Its Preclinical Oncology Drug Candidate
Provided By GlobeNewswire
Last update: Jun 11, 2025
Company to receive $7.0 million up front for its
preclinical oncology drug candidate
Up to $130.0 million in milestone payments starting with initiation of Phase 1
Read more at globenewswire.com1.05
+0.15 (+16.67%)
Find more stocks in the Stock Screener
WINT Latest News and Analysis
